Joint DIA/MEB “Excellence in Pharmacovigilance” Module 4: Risk Management

Module 4 focus on risk minimisation measures from both regulatory and industry perspectives. It also covers epidemiological methods used in Pharmacovigilance, as well as risk management plans.